Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jun 8;312(7044):1454-6.
doi: 10.1136/bmj.312.7044.1454.

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995

Affiliations

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995

A P Johnson et al. BMJ. .

Abstract

Objective: To assess the prevalence of antibiotic resistance and serotype distribution among pneumococci in England and Wales in 1990 and 1995.

Design: Observational surveys in March 1990 and March 1995. During two weeks in each survey period all pneumococci isolated in public health laboratories in England and Wales were collected and assessed for sensitivity to antibiotics and the distribution of serogroups or serotypes.

Setting: The network of public health laboratories throughout England and Wales.

Subjects: 1127 individual patient isolates of Streptococcus pneumoniae obtained during the two surveys.

Main outcome measures: Sensitivity or resistance to a range of antibiotics; serogroup or serotype.

Results: The prevalence of intermediate or full resistance to penicillin increased from 1.5% in 1990 to 3.9% in 1995 and resistance to erythromycin increased from 2.8% to 8.6%. About 92% of isolates belonged to serogroups or serotypes included in the currently available pneumococcal vaccine.

Conclusion: Resistance to penicillin and erythromycin has increased among pneumococci in England and Wales. Continued surveillance to assess further increases in the prevalence of pneumococcal resistance to antibiotics is essential.

PubMed Disclaimer

Comment in

References

    1. Microb Drug Resist. 1995 Spring;1(1):49-58 - PubMed
    1. Antimicrob Agents Chemother. 1995 Jan;39(1):238-40 - PubMed
    1. Antimicrob Agents Chemother. 1995 Sep;39(9):1988-92 - PubMed
    1. J Hosp Infect. 1991 Jan;17(1):15-23 - PubMed
    1. J Antimicrob Chemother. 1994 Nov;34(5):844-5 - PubMed

Publication types